Endonovo Therapeutics Inc (ENDV)

[Doyle McBoyle1]

Because I’d like to make money, no ones saying there isn’t money to be made here. One way we can take off is if they ramp up the sales of sofpulse, why do you think that’s not gonna happen? If sofpulse was made the main focus and we had more distribution and a decent amount of sales why wouldn’t we see movement to .10 and possibly hold there? Then maybe another institional investor comes on board. It just seems better for the short term the long term idea is more risky and really Is going to lose a lot of shareholder interest. And if shareholders aren’t even with this idea what makes you think an institutional investor is?